West Pharmaceutical(WST) - 2024 Q2 - Earnings Call Presentation

Notes to Non-U.S. GAAP Financial Measures (2) Net sales excluding divestitures represents the 2023 comparative sales figure used in our organic sales growth calculation to eliminate the impact of our 2023 divestiture. | --- | --- | --- | --- | |-------------------------------------------------------|-------------|----------------|--------------------| | | 2023 Actual | 2024 Guidance | % Change | | Reported-diluted EPS (U.S. GAAP) | $7.88 |$6.31 to $6.61 | (19.9%) to (16.1%) | | Loss on disposal of plant | ...